Tech2 years ago
Sam Altman invested $180 million into a company trying to delay death
There was reason to worry. In 2016, after Peter Thiel, one of Altman’s mentors, expressed interest in possibly getting age-defeating blood transfusions, he was mocked in...
Recent Comments